The Rise of a Biotech Superpower

Rebecca Fannin invites you to join us for our next group meeting, November 12, in NYC.

5pm: Registration & Networking

5:30 Welcome and Introductory Remarks

Briefing on Hong Kong's New Biotech Loop

Maisie Ho, Director, Hong Kong Economic and Trade Office in New York

As The Greater Bay Area (GBA) is rapidly transforming into a global biomedical powerhouse, Hong Kong plays a pivotal role for life sciences innovation and financing, supported by strong intellectual property (IP) protection, internationally aligned regulatory standards and proactive government initiatives. It offers companies unique advantages, including access to capital, opportunities for R&D collaboration and commercialisation, manufacturing scale-up capabilities and strategic gateway access to the vast Asian markets.
The business briefing will provide companies, investors and industry professionals with latest developments of Hong Kong’s Northern Metropolis, with an emphasis on the Hong Kong-Shenzhen Innovation and Technology Park, and the emerging opportunities they present for biotech and life sciences innovation.

Ruby Wang, Author, China Cure
Dr Ruby Wang is a British-Chinese physician, health and tech policy strategist and author of China Cure: The Rise of a Biotech, AI Medicine and Global Health Superpower (2026), which examines the global impact of China’ health innovation rise. She is the founder of LINTRIS Health, an international healthcare strategy consultancy advising multinational pharmaceutical and tech companies and investors between East and West, and editor at ChinaHealthPulse, a newsletter and podcast spotlighting trends across China and global markets.

Reception

Close: 7:30pm

Thanks to our host: HKETONY

(Registration required for event access.)